| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Revenue | $812.6M | +9.3% |
| Cost of Revenue | $460.4M | +22.8% |
| Gross Profit | $352.2M | -4.3% |
| R&D Expense | $249.7M | +13.7% |
| SG&A Expense | $107.4M | +14.5% |
| Operating Income | -$199.4M | -88.9% |
| Interest Expense | $19.4M | +3.9% |
| Pre-tax Income | -$229.7M | -120.3% |
| Income Tax | -$49.3M |
| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $606.3M | +57.5% |
| Short-term Investments | $369.9M | -49.6% |
| Accounts Receivable | $143.8M | +38.2% |
| Current Assets | $1.25B | -7.6% |
| Total Assets | $2.27B | -2.4% |
| Current Liabilities | $337.5M | +12.4% |
| Long-term Debt | $358.2M | +4.2% |
| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.9M | -134.0% |
| Capital Expenditures | $9.5M | -50.0% |
| Investing Cash Flow | $312.2M | +386.4% |
| Financing Cash Flow | -$37.3M | +76.6% |
| Free Cash Flow | -$47.5M | -151.3% |
| -30.5% |
| Net Income | -$180.4M | -171.3% |
| EPS (Basic) | -$2.16 | -173.4% |
| EPS (Diluted) | -$2.16 | -173.4% |
| Total Liabilities |
| $815.2M |
| +4.9% |
| Stockholders' Equity | $1.45B | -6.0% |